Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

eMed vs Lean Rx

eMed
Graded #398

Lower grade

vs+3.200000000000003
Lean Rx
Graded #318

Higher grade

The verdict

Lean Rx takes it — 60.6/100 to 57.4/100.

Lean Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Lean Rx is a Sacramento-based telehealth technology platform offering compounded GLP-1 weight loss medications.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueeMed +5
45
40
Dose & formulationLean Rx +35
40
75
Clinical oversighteMed +2
83
81
Labs & monitoringeMed +13
65
52
FulfillmenteMed +2
62
60
Contract termsEven
55
55
eMed · left barLean Rx · right bar

The numbers

MetriceMedLean Rx
WeighScore57.4/10060.6/100
GradeCC
Scorecard rank#398#318
SemaglutideNot disclosed$266/mo (starting dose, compounded)
TirzepatideNot disclosed$399/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
eMed

Graded #398 · C

Strengths

  • Prescribes FDA-approved branded GLP-1s (semaglutide and tirzepatide)
  • At-home blood collection makes lab work convenient
  • Clinician review and ongoing side-effect plus adherence support
  • Works with CVS Caremark so eligible employees can buy through benefits
  • Established digital health company with national scale

Where it loses points

  • Distributed mainly via employers, with limited direct cash-pay access
  • No public transparent monthly price for individuals
  • Eligibility and subsidy depend on what the employer chooses to cover
  • Best suited to workforces, not casual self-pay shoppers
Lean Rx

Graded #318 · C

Strengths

  • Both semaglutide and tirzepatide offered
  • Three formulations: injectable, sublingual, and tablet
  • Upfront pricing with no hidden fees advertised
  • Semaglutide starts at a low $266/month
  • Telehealth call with a licensed provider before prescribing

Where it loses points

  • Compounded-only; no FDA-approved branded options
  • No published state availability list
  • Platform is technology only, not a healthcare provider itself
  • Provider credentials not detailed on site

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard